Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rani Therapeutics Holdings (RANI) Interest & Investment Income (2020 - 2026)

Rani Therapeutics Holdings' Interest & Investment Income history spans 7 years, with the latest figure at $412000.0 for Q1 2026.

  • On a quarterly basis, Interest & Investment Income rose 88.99% to $412000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $1.0 million, a 28.58% decrease, with the full-year FY2025 number at $827000.0, down 53.09% from a year prior.
  • Interest & Investment Income came in at $412000.0 for Q1 2026, up from $384000.0 in the prior quarter.
  • The five-year high for Interest & Investment Income was $896000.0 in Q2 2023, with the low at $15000.0 in Q1 2022.
  • Historically, Interest & Investment Income has averaged $444117.6 across 5 years, with a median of $412000.0 in 2026.
  • Biggest five-year swings in Interest & Investment Income: soared 5840.0% in 2023 and later tumbled 83.57% in 2025.
  • Year by year, Interest & Investment Income stood at $818000.0 in 2022, then decreased by 17.48% to $675000.0 in 2023, then plummeted by 46.67% to $360000.0 in 2024, then rose by 6.67% to $384000.0 in 2025, then rose by 7.29% to $412000.0 in 2026.
  • Business Quant data shows Interest & Investment Income for RANI at $412000.0 in Q1 2026, $384000.0 in Q4 2025, and $68000.0 in Q3 2025.